|
Population or subpopulation of interest | Attribute | Proportion of populations with this attribute | Quality of informationa | References |
|
Oesophageal cancer |
All registry cancers | Oesophageal cancer | 0.01 | α | AIHW [3] |
Oesophageal cancer | Good PS | 0.80–0.91 | α δ | AIHW [3] NSW Population Health Survey [36] |
Oesophageal cancer | Metastatic disease | 0.26 | β | NSW Cancer Registry [37] |
Oesophageal cancer, localised disease | Resectable | 0.54–0.69 | θ |
Enzinger and Mayer [38] |
Oesophageal cancer, localised disease, operable | Recurrence | 0.66 | θ | Burmeister et al. [39] |
|
Gastric cancer |
All registry cancers | Gastric cancer | 0.02 | α | AIHW [3] |
Gastric cancer | Good PS | 0.76–0.89 | α δ | AIHW [3] NSW Population Health Survey [36] |
Gastric cancer | Metastatic disease | 0.29 | β | NSW Cancer Registry [40] |
Gastric cancer, locoregional disease | Resectable | 0.77 | δ | Wanebo et al. [41] |
Gastric cancer, resected stage 1A | Recurrence | 0.05 0.04 | ζ ζ | Yoo et al. [42] Sano et al. [43] |
|
Pancreatic cancer |
All registry cancers | Pancreatic cancer | 0.02 | α | AIHW [3] |
Pancreatic cancer | Below 80 years old | 0.72 | α | AIHW [3] |
Pancreatic cancer | Metastatic disease | 0.51 | β | NSW Cancer Registry [44] |
Pancreatic cancer, localised disease | Operable | 0.16 | γ | Janes Jr. et al. [45] |
Pancreatic cancer, advanced disease | Good PS | 0.30 | λ | Brasiunas et al. [46] |
|
Primary liver cancer |
All registry cancers | Liver cancer | 0.01 | α β | AIHW [3] NSW Cancer Registry [40] |
Liver cancer | Good PS | 0.90 | α δ | AIHW [3] NSW Population Health Survey [36] |
Liver cancer | Metastatic disease | 0.23 | β | NSW Cancer Registry [40] |
Liver cancer, localised disease | Resectable | 0.23 | γ | NCDB [5] |
Liver cancer, localised disease, unresectable | Suitable for chemoembolisation | 0.38 | ε | Llovet et al. [47] |
Liver cancer, localised disease, resectable | Recurrence | 0.2–0.33 | θ | Jaeck et al. [48] |
Liver cancer, localised disease, resectable, recurrence | Intrahepatic recurrence only | 0.83 0.74 | ζ ζ | Yang et al. [49] Cha et al. [50] |
Liver cancer, localised disease, resectable, intrahepatic recurrence only | Suitable for chemoembolisation | 0.68 0.58 | λ λ | Poon et al. [51] Takayasu et al. [52] |
|
Gallbladder cancer |
All registry cancers | Gallbladder cancer | 0.01 | α | AIHW [3] |
Gallbladder cancer | Good PS | 0.68 | α δ | AIHW [3] NSW Population Health Survey [36] |
Gallbladder cancer | Locoregional, recurrence | 0.85–0.95 | γ | NCDB [8] |
Gallbladder cancer | Metastatic disease | 0.37 | γ | SEER [53] |
Gallbladder cancer | Stage IA | 0.12 | γ | NCDB [8] |
|